The needs of patients receiving depot antipsychotic medication within primary care

被引:3
|
作者
Phelan, M
Mirza, L
机构
[1] Acad Ctr, St Bernards Wing, Uxbridge UB1 3EU, Middx, England
[2] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Psychiat, London, England
关键词
depot antipsychotic; needs assessment; schizophrenia;
D O I
10.1093/fampra/20.2.126
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Depot antipsychotic medication is a vital treatment for many people with schizophrenia. Many patients receive this medication from primary care, and have little or no contact with specialist mental health services. Objective. The aim of the present study was to compare the characteristics and needs of patients receiving depot medication within primary care with those receiving their medication from specialist mental health services. Methods. A total of 58 patients were identified from four primary care teams. Data were collected from medical records, and staff interviews were conducted using standardized interview schedules. Results. Patients receiving medication from primary care had more than twice as many health and social needs compared with those receiving medication from specialist services. Conclusions. There are advantages for patients to receive depot medication from primary care, but the needs of the patients must be reviewed regularly, and primary care staff must have easy access to specialist mental health services.
引用
收藏
页码:126 / 128
页数:3
相关论文
共 50 条
  • [1] COMMUNITY CARE OF PATIENTS RECEIVING ANTIPSYCHOTIC MEDICATION BY DEPOT INJECTION
    WESBY, R
    EARLE, J
    BULLMORE, E
    HEAVEY, A
    BRITISH JOURNAL OF GENERAL PRACTICE, 1993, 43 (367): : 83 - 84
  • [2] PREVALENCE OF EXTRAPYRAMIDAL SIDE EFFECTS IN PATIENTS RECEIVING DEPOT ANTIPSYCHOTIC MEDICATION
    Luft, B.
    Berent, E.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [3] PATIENTS' ATTITUDES TO ANTIPSYCHOTIC DEPOT MEDICATION
    Mnif, L.
    Masmoudi, J.
    Baati, I.
    Masmoudi, R.
    Damak, R.
    Jaoua, A.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [4] DAYTIME VARIATION IN SERUM PROLACTIN LEVELS IN PATIENTS RECEIVING ORAL AND DEPOT ANTIPSYCHOTIC MEDICATION
    GOODE, DJ
    MELTZER, HY
    FANG, VS
    BIOLOGICAL PSYCHIATRY, 1981, 16 (07) : 653 - 662
  • [5] Side-Effect Monitoring for Patients on Depot Antipsychotic Medication Within a Community Treatment Team
    Waterman, Harry
    Zaborowska, Hanna
    Taylor, Julie
    BJPSYCH OPEN, 2023, 9 : S186 - S187
  • [6] Side-Effect Monitoring for Patients on Depot Antipsychotic Medication Within a Community Treatment Team
    Waterman, Harry
    Zaborowska, Hanna
    Taylor, Julie
    BJPSYCH OPEN, 2023, 9 : S186 - S187
  • [7] FEASIBILITY OF DISCHARGE TO PRIMARY CARE OF PATIENTS ON LONG-TERM DEPOT ANTIPSYCHOTIC
    Castelino, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2015, 49 : 106 - 106
  • [8] Electrocardiographic changes in patients receiving antipsychotic medication
    Eder, U
    Hochleitner, M
    Weiss, E
    Hummer, M
    Fleischhacker, WW
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 354 - 355
  • [9] Depot antipsychotic medication in the treatment of patients with schizophrenia: A systematic review
    Fenton, MK
    Adams, CE
    Quraishi, S
    David, AS
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 188 - 188
  • [10] Compliance with depot antipsychotic medication by patients attending outpatient clinics
    Heyscue, BE
    Levin, GM
    Merrick, JP
    PSYCHIATRIC SERVICES, 1998, 49 (09) : 1232 - 1234